These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32295147)

  • 1. Antioxidative Activity of 1,3,5-Triazine Analogues Incorporating Aminobenzene Sulfonamide, Aminoalcohol/Phenol, Piperazine, Chalcone, or Stilbene Motifs.
    Havránková E; Čalkovská N; Padrtová T; Csöllei J; Opatřilová R; Pazdera P
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32295147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action.
    Havránková E; Csöllei J; Vullo D; Garaj V; Pazdera P; Supuran CT
    Bioorg Chem; 2018 Apr; 77():25-37. PubMed ID: 29324250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX.
    Mikuš P; Krajčiová D; Mikulová M; Horváth B; Pecher D; Garaj V; Bua S; Angeli A; Supuran CT
    Bioorg Chem; 2018 Dec; 81():241-252. PubMed ID: 30153589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Approach for the One-Pot Synthesis of 1,3,5-Triazine Derivatives: Application of Cu(I) Supported on a Weakly Acidic Cation-Exchanger Resin in a Comparative Study.
    Havránková E; Csöllei J; Pazdera P
    Molecules; 2019 Oct; 24(19):. PubMed ID: 31590377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.
    Jameel E; Meena P; Maqbool M; Kumar J; Ahmed W; Mumtazuddin S; Tiwari M; Hoda N; Jayaram B
    Eur J Med Chem; 2017 Aug; 136():36-51. PubMed ID: 28478343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convenient synthesis of fused heterocyclic 1,3,5-triazines from some N-acyl imidates and heterocyclic amines as anticancer and antioxidant agents.
    Bekircan O; Küxük M; Kahveci B; Kolayli S
    Arch Pharm (Weinheim); 2005 Aug; 338(8):365-72. PubMed ID: 16041836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperazine derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists.
    Vu CB; Peng B; Kumaravel G; Smits G; Jin X; Phadke D; Engber T; Huang C; Reilly J; Tam S; Grant D; Hetu G; Chen L; Zhang J; Petter RC
    J Med Chem; 2004 Aug; 47(17):4291-9. PubMed ID: 15294001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylsulfonyl piperazine bridged [1,3]dioxolo[4,5-g]chromenones as promising antiproliferative and antioxidant agents.
    Patel RV; Mistry BM; Syed R; Parekh NM; Shin HS
    Bioorg Chem; 2019 Jun; 87():23-30. PubMed ID: 30852234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. o-Carboranylalkoxy-1,3,5-Triazine Derivatives: Synthesis, Characterization, X-ray Structural Studies, and Biological Activity.
    Jin GF; Ban HS; Nakamura H; Lee JD
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30200261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative structure-activity relationship of triazine-antifolate inhibition of Leishmania dihydrofolate reductase and cell growth.
    Booth RG; Selassie CD; Hansch C; Santi DV
    J Med Chem; 1987 Jul; 30(7):1218-24. PubMed ID: 3599028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides.
    Arslan T; Türkoğlu EA; Şentürk M; Supuran CT
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5867-5870. PubMed ID: 27884694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traceless solid-phase synthesis of 6-amino- and 6-hydroxyimino-1,3,5-triazine-2,4-diones and 1,3,5-triazine-2,4,6-triones.
    Kong KH; Tan CK; Lam Y
    J Comb Chem; 2009; 11(6):1050-60. PubMed ID: 19817460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antimicrobial activity of N¹-benzyl or N¹-benzyloxy-1,6-dihydro-1,3,5-triazine-2,4-diamines.
    Ma X; Tan ST; Khoo CL; Sim HM; Chan LW; Chui WK
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5428-31. PubMed ID: 21788136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on as-triazine derivatives. XVIII. Synthesis of 5,6-diaryl-1,2,4-triazine derivatives as blood platelet aggregation inhibitors].
    Konno S; Kokubo T; Amano M; Yoshida N; Sagi M; Yamanaka H
    Yakugaku Zasshi; 1992 Oct; 112(10):729-41. PubMed ID: 1469603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,3,5-Triazines: A promising scaffold for anticancer drugs development.
    Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
    Eur J Med Chem; 2017 Dec; 142():523-549. PubMed ID: 29046238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of pyrazolo[4,3-e][1,2,4]triazine sulfonamides, novel Sildenafil analogs with tyrosinase inhibitory activity.
    Mojzych M; Dolashki A; Voelter W
    Bioorg Med Chem; 2014 Dec; 22(23):6616-6624. PubMed ID: 25456386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial synthesis of galactosyl-1,3,5-triazines as novel nucleoside analogues.
    Wang S; Lee WS; Ha HH; Chang YT
    Org Biomol Chem; 2011 Oct; 9(20):6924-6. PubMed ID: 21863155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Synthesis of New JAK1 Inhibitors based on Sulfonamide- Triazine Conjugates.
    Daoud S; Taha MO
    Curr Comput Aided Drug Des; 2021; 17(7):916-926. PubMed ID: 33357183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionalized triazines as potent HCV entry inhibitors.
    Mull ES; Sun LQ; Zhao Q; Eggers B; Pokornowski K; Zhai G; Rajamani R; Jenkins S; Kramer M; Wang YK; Fang H; Tenney D; Baldick CJ; Cockett MI; Meanwell NA; Scola PM
    Bioorg Med Chem Lett; 2017 Feb; 27(4):1089-1093. PubMed ID: 28089701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.